Search the Community

Patients and Caregivers are discriminated upon in many facets of life, be it employment, housing, education, student loans, banking, travelling, medical care, prescription medical care, parental rights... and in this case, Emergency Medical Care! My client is a Michigan Medical Marijuana patient who was having an emergency. An ambulance picked him up, and against his hospital preference, the ambulance took him to the U of M Ann Arbor Hospital. While at the hospital, the patient, my client, in response to the standard medical care question of "list any other medications you are currently taking", was honest and replied that he uses a topical marijuana oil. He used the oil at the recommendation of his primary care physician to help with his cancer and chronic pain. He had the oil in his belongings when he was brought to the hospital. The Registered Nurse at the hospital then called the Hospital Security Officer, who then confiscated the patients medical marijuana oil and called the police. Why is the Physician - Patient privileged relationship being violated like this? My client told his nurses that he was a MMMA patient, those same nurses told the HSO and police officer he told them he was a MMMA patient as well. So what gives? The police have the discretion to investigate or talk to people instead of making a case out of something. Why waste time on investigating a medical marijuana patient? The police officer sent the topical marijuana oil to the Michigan State Crime Lab for testing, coming back positive for THC. The police officer forwarded the lab report to the Washtenaw County Prosecutors Office for prosecution. The WCPO then filed charges against this MMMA patient. All for .5 oz of topical oil marihuana-infused product that the patient had in his bag. Of course the prosecutors office did not blink an eye, nor did they use prosecutorial discretion. They issued the charges and sent the warrant to me so that I could have my client turn himself in. This is called a pre-arrest investigation at my office. If you ever have a police interaction but are not arrested, it means they are waiting on lab results. After they get the lab results back , they send out the warrant and arrest you wherever they can find you. Be it at your Home, work, school or driving on the road. When they arrest you at Home, they search your house. When they arrest you at work, you may have to explain to your boss what happened. When they arrest you at school you will be embarrassed. When they arrest you on the road, either you have to get someone to pick up your car or they will tow it. They will search your car as well. Then you have to post bond to get out of jail too. So hiring an attorney that will handle all of that, so you can turn yourself in, not speak to the police, and be arraigned and have usually a personal recognizance bond (meaning you don't have to pay anything, just have to show up at your next court date) is helpful in avoiding a bad situation. This is happening in Ann Arbor of all places? The city that decriminalized Marijuana down to a $25 civil infraction fine? U of M is state property, since it gets state funding. My Advice? If you are a Patient or Caregiver (or not a patient/caregiver) , never admit to anyone that you are possessing marijuana. Marijuana is currently still illegal and currently there are still people who WILL CALL THE POLICE ON YOU for having marijuana. In this case the patient did not have his card at the time he was hospitalized, but registered with the state afterwards. We prepared a Section 8 defense to the crime of possession of marijuana and were ready to battle in court. Instead of our Section 8 evidentiary hearing, instead of the prosecutor wanting to cross examine my client's physician, instead of testifying and all of the pain of a Section 8 defense, we went with a quick Section 4 dismissal. The prosecutor was SHOCKED that my client could not be prosecuted due to having his card now. Judge agreed and the case is dismissed. If you were charged with marijuana possession or manufacture, give me a call. I will fight to get the charges dismissed. 18006563557 http://www.komornlaw.com

Even in a Midterm off season election, Medical Marijuana wins all. https://yeson788.com/sq-788 https://ballotpedia.org/Oklahoma_State_Question_788,_Medical_Marijuana_Legalization_Initiative_(June_2018)

On Friday May 4, 2018 a review panel recommended 10 new conditions to be added to the list of ailments for approval for use of medical marijuana in Michigan. Obsessive compulsive disorder Arthritis Rheumatoid arthritis Spinal cord injury Inflammatory bowel disease Ulcerative colitis Parkinson’s Tourette Syndrome Autism Chronic pain A Michigan regulator (Shelly Edgerton) who is The Department of Licensing and Regulatory Affairs Director has until July 10, 2018 to make a decision on nine of the recommendations and until Aug. 6 to make a decision on another. Only post-traumatic stress disorder has been added since 2008.

LARA is holding another public hearing, hoping to break the 3-3 tie that was set on the 5-4-2018 meeting to hear new petitions to add qualifying conditions to the Michigan Medical Marijuana Act. Please show up if you can and help support the new conditions for the patients and parents who could not be there themselves. Just showing up makes a difference! NOTICE OF PUBLIC HEARING Medical Marihuana Review Panel June 14, 2018 9:30 A.M. Location: Williams Building 1st Floor Auditorium 525 W Ottawa St, Lansing, MI 48933 AGENDA The public hearing is for the Medical Marihuana Review Panel (Review Panel) to review petitions to include a particular medical condition or treatment to the list of debilitating medical conditions pursuant to the Michigan Medical Marihuana Act, 2008 IL 1, MCL 333.26421 to 333.26430 (MMMA). The petitions before the Review Panel under the MMMA are as follows: colitis, organ transplant, and non-severe and non-chronic pain. And any other business properly before the Review Panel.

Parents and caregivers of children and persons with Autistic Spectrum Disorder have been fighting to try medical marijuana as an option after exhausting all other treatment options available. This fight has been going on for at least 5 years, when LARA denied the petition for autism in 2013. In 2013, the review panel voted 2 yes and 7 no votes. The 2013 petition lacked any research or studies, so parents Dwight Z. and Dr Christian Bogner submitted a new autism petition with studies and help from researcher Joe Stone in 2014. 10/4/13 Final Determination of Department - Autism 8/27/15 Final Determination of Department - Autism LARA rejected the 2014 petition because they had made a "final decision" on autism in 2013. Michael Komorn, president of the Michigan Medical Marijuana Association, filed a lawsuit against LARA to get them to hear the 2014 petition. After months of stalling from LARA they finally decided to hear the petition, and in May 2015, the review panel heard the petition and testimony. LARA tried a dirty trick by not sending the research and studies to the panel. This was brought to the attention of the panel that research was submitted, so the board came back a week later to give time to the panelists to review the research. The panel then voted 4 yes and 2 no votes to approve Autism as a qualifying condition. In August 2015, the Director of LARA, Mike Zimmer, then rejected adding autism as a qualifying condition to the Medical Marihuana program against the wishes of the panel. In his rejection, Mr. Zimmer gave the reason that edibles may be illegal due to a confusing ruling from the Court of Appeals among other objections. Parents and caregivers of people diagnosed with autism continued to fight, and worked together to submit another autism petition. Adding 20 new peer-reviewed research studies from the past 4 years. The new autism petition was submitted in February and was sent by LARA and heard by the review panel on 4-27-2018. Wonderful and brave parents Amie Carter and Jamie Cooper testified before the panel, laying their hearts and family stories out there for the world to gawk at. At the following review panel meeting on 5-4-2018, the review panel approved of 10 conditions including Autism in a 6 yes and 1 no vote. Voting no on a condition is voting to subject the rejected-condition patient to arrest for the medical use or possession of marihuana. A suggestion was made by a panel member that the marijuana legalization ballot initiative would save any concerns for the denied patient conditions. This is not true. There are several differences between legalization and the medical marijuana program that would negatively affect a patient. First, the recreational marijuana initiative will apply a large tax and other costs that would not apply to patients if they were part of the MMM program. Second, patients are treated in the law differently regarding several issues. · Driving · Housing · CPS / Parenting / Custody issues · Employment · Immunities and Affirmative Defense Patients should not be punished for their use of cannabis when it is medical and not for adult recreation. Medical use and recreational use have significant distinctions, that were played out in the discussion of the panel and specifically the experience shared by Dr. Crocker who sees a variety patients with various diseases that are treated by cannabis. It makes no sense to deny the petition for these conditions when the evidence supports the therapeutic and palliative relief. 1. The panel are ignoring the reality of what a “no vote” is and means to patients. 2. The excuses used to deny or vote no have been: · Not enough research · Not enough clinical trials Panel members have lamented on this topic for years, but this argument makes no sense. Why would they approve of some conditions but not others, as they have given this reason for rejecting conditions? No condition has been thoroughly researched to use with marijuana. Absolutely zero clinical trials for any condition have been performed with crude marijuana flowers. Even though marijuana smoking has been shown to absolutely stop epileptic seizures, reduce eye pressure in glaucoma patients, open up airways in asthma patients, return appetite to AIDS patients, prevent nausea, reduce anxiety/stress and control pain signals. There are few, small, less than 100 people research studies on a few small conditions. Those studies are conducted only with Marinol, Sativex or other pharmaceutical formulations, not crude marihuana flowers and extracts. The FDA refuses to study crude marijuana extracts and flowers, and prefers a mono chemical therapy. One plant chemical, THC. Recently the FDA has been testing CBD. Two plant chemicals total from over 400 known cannabinoids (plant chemicals) within the cannabis plant. At this rate, the FDA will have tested each of the 400 cannabinoids separately within 16,000 years. Counting 40 years for THC-only studies, 40 years x 400 cannabinoids = 16,000 years. Which is why, the American people have bypassed the FDA and have approved marijuana as a medicine on a state by state basis. Sick people cannot wait for the FDA to continue to hamper research and deny that marijuana is a medicine. All because the FDA refuses and prefers a single chemical standardized consistent drug. These are terrible reasons because research on marijuana has been hampered. We mentioned this in our petition https://www.nytimes.com/2010/01/19/health/policy/19marijuana.html · Dr. Crocker and other physicians have conflated marijuana smoke and tobacco smoke and then offered and relied upon this unproven fact that the two smokes are the same and have the same health effects. Marijuana smoke is different than Tobacco smoke and has different effects on humans and animals. See The large studies on lung function by Dr Tashkin and all of the other studies that show the only difference between a non-smoker and a marijuana-only smoker is that the marijuana-only smoker has a larger forced air lung capacity. Effects of smoked marijuana in experimentally induced asthma. Effects of cannabis on lung function: a population-based cohort study · Legalization, if the review panel does not approve a condition, the sick patient can possess by adult recreational means. The review panelist who made this comment is a physician and in her reason for denial of the petition is saying that a person should self-medicate! Unheard of advice from a physician. · The panel mentioned several times that they wanted “severe” conditions, severe brain injury vs brain injury or severe autism vs autism. Aren't people with less severe conditions allowed treatment? Are we equal or are severe conditions more important? Nothing about this reason makes any sense to deny a condition from this non-toxic safe medication. The review panel is supposed to look at each individual petition, and only those petitions, to determine if the condition should be added to the MMMA. Frequently, the panel members have made comments or asked questions about other conditions while debating petitions. "Why are we voting on "chronic pain" when "severe and chronic pain" is a qualifying condition?" "Why are there petitions for Arthritis and Rheumatoid Arthritis?" "Brain Injury is too vague, but Traumatic Brain Injury is a condition that may be more appropriate" "Colitis is too broad, colitis can be infectious or non-infectious" Panelist Dr Lewandowski said there was only one "good" study that showed "clinical improvement with dronabinol in this submission" of obsessive compulsive disorder and "this meet the expectation in support of peer-reviewed information". All of the research we submitted in our petitions was peer-reviewed except for one paper on Autism, all of the studies showed palliative or therapeutic benefit and efficacy. The requirements by LARA are the following: Provide a summary of the evidence that the use of marihuana will provide palliative or therapeutic benefit for that medical condition or a treatment of that medical condition. Rule 33(1)(a). Include articles published in peer-reviewed scientific journals reporting the results of research on the effects of marihuana on the medical condition or treatment of the medical condition and supporting why the medical condition or treatment should be added to the list of debilitating medical conditions under section 3(b) of the MMMA, MCL 333.26423(b). Rule 33(1)(b). Note that Lewandowski's remarks about clinical improvement is not a requirement within the MMMA, the LARA Administrative rules, nor the Petitions themselves. The whole point about medical marijuana programs is that we cannot get marijuana into clinical studies. Cannabis's schedule 1 status, FDA monotherapy rules, NIDA grant bias for harms not benefits, DEA hoop jumping, propaganda and political football including bribery, corruption and market forces (from private prison unions, alcohol, tobacco and Big Pharma industry not wanting competition) makes it incredibly difficult and near impossible to study marijuana for medical benefits. Tabled conditions: · Non chronic non severe pain · Colitis · Organ Transplant

Tampa doctor uses medical marijuana to treat patients with autism

The autism petition has been approved by the Michigan Medical Marijuana Review Panel on 5-4-2018 and has been sent to the Director of LARA for a final decision to add the condition to the qualifying conditions for the Medical Marihuana Program. In the mean time, physicians in other states use medical marijuana to treat autistic patients already. http://www.wfla.com/community/health/tampa-doctor-uses-medical-marijuana-to-treat-patients-with-autism/1153159741

A large private donation will fund another study on using medical marijuana for autism. But this is not the first, nor is it the last clinical study on marijuana for autism. Marijuana aka Cannabis regulates the body and mind into a more normative state. Cannabis is also a very strong anti-inflammatory, and thus relieves a lot of pain. Many people with autism also suffer from pain, but are unable to communicate their pain. The autistic person in pain unable to communicate then manifests into aggression, irritability, self-injurious behavior, screaming and other outbursts. With the help of parents and physicians, the Michigan Medical Marihuana Association has submitted autism to be a qualifying condition again with the Michigan Medical Marihuana Review Panel. There will be a meeting on May 4th 2018 at 9am in Lansing, MI where the panel will vote on autism along with 21 other new proposed conditions. Please if you can show up to the meeting and give your support to the board members so they support adding these conditions to the Michigan Medical Marijuana Program. While we at the MMMA of course support more research on cannabis for all conditions, it is cruel to prohibit this safe non-toxic medicine from people who suffer and may already be using cannabis illegally to treat autism. If you want to leave a public comment, the deadline is 5/3/2018 at 5pm to email comments to LARA-BMMR-Legal@michigan.gov http://komornlaw.com/wp-content/uploads/2018/04/MMRP_Notice_of_Public_Hearing_5.4.18_618072_7.pdf http://komornlaw.com/wp-content/uploads/2018/04/MMRP_Notice_of_Public_Hearing_4.27.18_618073_7.pdf Autism is a qualifying medical marijuana condition in California, Minnesota and Pennsylvania. https://www.pa.gov/guides/pennsylvania-medical-marijuana-program/ http://www.health.state.mn.us/news/pressrel/2017/cannabis113017.html https://www.mprnews.org/story/2017/11/30/minnesota-oks-medical-marijuana-for-autism-apnea The main "treatment" for autism is Applied Behavior Analysis (ABA). ABA is mostly about teaching behaviors and correcting unwanted behaviors as you would train a dog or animal. ABA does not treat the person itself, nor does it diagnose, treat or check for pain or discomfort. ABA is akin to a nun using capital punishment using whips and canes to "fix problem children". https://www.entrepreneur.com/article/312723 https://www.cmcr.ucsd.edu/index.php/2015-11-20-20-52-15/active-studies/123-the-effects-of-cannabidiol-cbd-on-symptoms-of-severe-autism Although the above clinical trial is still in Phase 1 and has not started yet, there are other clinical trials which have advanced to phase 2. An interesting clinical trial below is part of the US Department of Defense budget. https://clinicaltrials.gov/ct2/show/NCT03202303 This clinical trial in Israel seems to be more fleshed out and has more information. https://clinicaltrials.gov/ct2/show/NCT02956226 http://www.nbc4i.com/news/u-s-world/dad-uses-medical-marijuana-to-treat-daughter-with-autism/1102805672 http://www.wfla.com/community/health/tampa-doctor-uses-medical-marijuana-to-treat-patients-with-autism/1153159741

The Michigan Medical Marijuana Association has submitted a petition for treating opioid dependence with medical marijuana. The public hearing for public comments will be heard on April 27, 2018. Read more about it at http://komornlaw.com/petitions Pa. approves sale of marijuana 'flower,' and will allow cannabis to treat opioid addiction Updated: APRIL 16, 2018 — 5:58 PM EDT by Sam Wood, Staff Writer @samwoodiii | samwood@phillynews.com The price of medical marijuana could fall dramatically for some patients by mid-summer. And the drug will soon be used to treat opioid withdrawal in Pennsylvania, which will become the second state after New Jersey to allow it for that purpose. At a news conference in Harrisburg, Secretary of Health Rachel Levine said she had approved the sale of cannabis flower, the traditional smokable or vaporizable form of the plant. “It’s another tool,” Levine said. “The whole idea of this program is to provide another tool in the toolbox of physicians to treat these conditions.” Since the launch of the state medical marijuana program in February, dispensaries in Pennsylvania have sold only pricey marijuana oils and extracts. Flower, also known as leaf or bud, needs no processing and is less expensive to produce. “For some patients, the cost of their medical marijuana could drop by 50 percent with the addition of flower,” said Chris Visco, owner of TerraVida Holistic Centers, a chain of dispensaries with shops in Sellersville and Abington. “It offers the lowest price per milligram of THC, the active ingredient.” Marijuana producer Charlie Bachtell, CEO of Cresco Yeltrah, said being able to sell plant material will streamline a large part of his production. “We just have to weigh it and put it in a container,” he said. “There’s no manual labor turning it into something else, whether it’s filling a capsule or filling a vape pen. Every time someone touches it, it makes it more expensive.” Though smoking cannabis is prohibited by Pennsylvania law, the difference between lighting up and vaporization is literally a matter of degrees. Vaporizing requires less intense heat and a specialized electronic device so that the marijuana doesn’t combust, but the method delivers the same psychoactive and physical effects as smoking. (To discourage smoking, dispensaries are forbidden from vending pipes, bongs and rolling papers.) Nearly all of the 29 states that have legalized marijuana in some form allow for the distribution of plant material. Minnesota and West Virginia are among the last weed-legal states with laws banning its sale. Levine accepted more than a dozen recommendations made last week by the state’s medical marijuana advisory board. With her decision, doctors will still need to register but will be able to opt out of the published registry. Terminal illness, neurodegenerative diseases, and dyskinetic and spastic movement disorders are now qualifying conditions. Allowing the use of cannabis to help wean people off of opioids may have the greatest impact on the state. New Jersey was the first to approve “addiction substitute therapy for opioid reduction” last month. By adding treatment for opioid withdrawal to the list of approved uses, Levine opened up the possibility for clinical research on the two drugs at state health systems. “This is major news,” said physician Sue Sisley, founder of the Scottsdale Research Institute, where she researches medical marijuana’s effects on PTSD in veterans. “We have all these opioid task forces in so many states, and almost none of them even mention cannabis as a substitution for opioids as part of the treatment strategy.” Sisley called Levine’s decision “courageous” but warned it could be politically “radioactive.” “It’s a very conservative medical environment you have in Pennsylvania,” said Sisley, who serves on the steering committee of Jefferson’s Lambert Center for the Study of Medicinal Cannabis and Hemp in Philadelphia. “But Dr. Levine recognizes she needs to solve the problem and start preventing all these deaths that are all so preventable.” Advocates applauded the evolution of the state marijuana program. “I am ecstatic today,” said State Sen. Daylin Leach (D., Montgomery), who helped drive the legislation that became the state’s medical marijuana law. “Allowing the whole plant will dramatically expand the number of patients who benefit from medical cannabis and will go a long way toward guaranteeing that this huge new industry survives and prospers.” Becky Dansky, legislative counsel of the Marijuana Policy Project, said that allowing the sale of flower represented more than a cheaper option for patients, many of whom are on disability. “For many patients, it’s the best form to treat their symptoms,” Dansky said. “The key now is to get it on the shelves as soon as possible.” http://www.philly.com/philly/business/cannabis/marijuana-medical-flower-opioid-addiction-therapy-rachel-levine-cresco-terravida-20180416.html

Pregnancy and Medical Marijuana Expectant mothers are searching for answers about the safety profile of Medical Marijuana. Unfortunately the scientific community has dropped the ball and kicked it off the cliff on this issue. The lack of scientific research is due to marijuana’s illegality. Further, there exist huge biases within the published research. Mostly the research confounds marijuana use with tobacco and/or alcohol, two known causes of fetus and child harm. Separating out marijuana effects from the self-reported research on mothers who also smoke tobacco and drink alcohol is impossible. Likewise no pregnant women are signing up for research studies due to the illegality of marijuana and CPS removing children from mothers for testing positive for marijuana use. Many organizations quote from other organizations, who quote from other studies and reviews. The Minnesota Department of Health OFFICE OF MEDICAL CANNABIS quotes from the American College of Obstetricians and Gynecologists Committee report: In the American College of Obstetricians and Gynecologists official committee opinion, interim update Oct 2017, the committee found: Uninformed opinion, with zero evidence and lots of fear, uncertainty and doubt (FUD) are used to scare mothers away from a nontoxic plant. These uninformed unscientific opinions are being used by lawmakers to craft laws continuing the cycle of FUD and the illegality of marijuana. “Oh we don’t know what marijuana does, so let’s treat it like heroin” and “if anyone questions our opinion of marijuana, we’ll call them dirty lazy pothead stoner hippies” or “puppets of the marijuana industry”. But we do know what marijuana does. One cannot live in a bubble and ignore reality and the world around us. Women smoke and eat marijuana while pregnant. Cannabis use during pregnancy in France in 2010 Trends in Self-reported and Biochemically Tested Marijuana Use Among Pregnant Females in California From 2009-2016 http://news.gallup.com/poll/194195/adults-say-smoke-marijuana.aspx Much of the opinions on marijuana are tainted by a small number of poorly designed studies on marijuana. For example, the National Institute of Health gives grants to researchers through NIDA, the National Institute of Drug Abuse, to study marijuana. NIDA’s focus is on drug abuse, so 90% of its grants are for studies on marijuana abuse, not marijuana benefits. When you ignore half of your research, you ignore science. Many of these studies are completed in order to get future grants from NIDA; research is often conducted from the conclusion backwards in order to show some kind of harm from marijuana use. This, in of itself, does not bias research. https://www.nytimes.com/2010/01/19/health/policy/19marijuana.html The bias is introduced when researchers are rushed and forced to publish results, even if the studies were deficient. For example, every website and newspaper ran with the story about marijuana using children lose IQ points. Not many reported on the follow-up study that could not replicate the first study. When eliminating co-founders, the new study found no drop in IQ points. Further, research on twin siblings showed that the drop in IQ was due to parenting, binge drinking or other societal influences, not marijuana. https://www.drugabuse.gov/news-events/nida-notes/2016/08/study-questions-role-marijuana-in-teen-users-iq-decline Try reading that last sentence again. In a world of science, evidence, reasoning and logic, a doctor makes a statement that decades of use of marijuana might make you lose intellectual function, based on conjecture. NIDA also continues to perpetuate the myth that Marijuana is a “gateway drug”. https://www.drugabuse.gov/publications/research-reports/marijuana/marijuana-gateway-drug These findings are consistent with the idea of marijuana as a "gateway drug." However, the majority of people who use marijuana do not go on to use other, "harder" substances. NIDA, NIH, FDA, DEA, including other federal, state, and local government organizations and private companies continue to perpetuate these and other lies in order to keep marijuana illegal. ASA has filed complaints against the DEA multiple times to get it to remove incorrect statements about marijuana off of the DEA’s website. http://www.safeaccessnow.org/iqa_victory A cyclical pattern emerges from the current and past situation surrounding marijuana. 1. Stymied scientific research, due to illegality of marijuana and government funding biases 2. Using stymied scientific research as a reason to ignore reality. 3. Repeating the biased scientific research, long after it was shown to be deficient. 4. Using the deficient biased research in “meta-reviews”. Thus taking bad science as a base to create more bad science just by doing an analysis of the bad science conclusions. 5. Even after a research study has been fully proven to be deficient and conflicting with better research, continue to hold it up as if it is still valid in some way. 6. Publish opinions as if they were facts, without any data to back up any claims. Continue reading for more conflicting studies and more calls for research. Marijuana: Prenatal and Postnatal Exposure in the Human Marijuana use in pregnancy and lactation: a review of the evidence Marijuana and Pregnancy The Association of Marijuana Use with Outcome of Pregnancy Prenatal Tobacco, Marijuana, Stimulant, and Opiate Exposure: Outcomes and Practice Implications Many of these studies contradict themselves. Some report differences in birth weight, some show no differences. Read the studies yourself! http://legislature.mi.gov/doc.aspx?2017-HB-5222 House bill 5422 will force MMFLA provisioning centers to give patients and caregivers an unscientific pamphlet, as described by the legislature. HB 5222 looks like it will pass. All this fear and doubt of a non-toxic 5,000+ year old medication used by millions of humans in every country in the world.

Pregnancy and Medical Marijuana Expectant mothers are searching for answers about the safety profile of Medical Marijuana. Unfortunately the scientific community has dropped the ball and kicked it off the cliff on this issue. The lack of scientific research is due to marijuana’s illegality. Further, there exist huge biases within the published research. Mostly the research confounds marijuana use with tobacco and/or alcohol, two known causes of fetus and child harm. Separating out marijuana effects from the self-reported research on mothers who also smoke tobacco and drink alcohol is impossible. Likewise no pregnant women are signing up for research studies due to the illegality of marijuana and CPS removing children from mothers for testing positive for marijuana use. Many organizations quote from other organizations, who quote from other studies and reviews. The Minnesota Department of Health OFFICE OF MEDICAL CANNABIS quotes from the American College of Obstetricians and Gynecologists Committee report: In the American College of Obstetricians and Gynecologists official committee opinion, interim update Oct 2017, the committee found: Uninformed opinion, with zero evidence and lots of fear, uncertainty and doubt (FUD) are used to scare mothers away from a nontoxic plant. These uninformed unscientific opinions are being used by lawmakers to craft laws continuing the cycle of FUD and the illegality of marijuana. “Oh we don’t know what marijuana does, so let’s treat it like heroin” and “if anyone questions our opinion of marijuana, we’ll call them dirty lazy pothead stoner hippies” or “puppets of the marijuana industry”. But we do know what marijuana does. One cannot live in a bubble and ignore reality and the world around us. Women smoke and eat marijuana while pregnant. Cannabis use during pregnancy in France in 2010 Trends in Self-reported and Biochemically Tested Marijuana Use Among Pregnant Females in California From 2009-2016 http://news.gallup.com/poll/194195/adults-say-smoke-marijuana.aspx Much of the opinions on marijuana are tainted by a small number of poorly designed studies on marijuana. For example, the National Institute of Health gives grants to researchers through NIDA, the National Institute of Drug Abuse, to study marijuana. NIDA’s focus is on drug abuse, so 90% of its grants are for studies on marijuana abuse, not marijuana benefits. When you ignore half of your research, you ignore science. Many of these studies are completed in order to get future grants from NIDA; research is often conducted from the conclusion backwards in order to show some kind of harm from marijuana use. This, in of itself, does not bias research. https://www.nytimes.com/2010/01/19/health/policy/19marijuana.html The bias is introduced when researchers are rushed and forced to publish results, even if the studies were deficient. For example, every website and newspaper ran with the story about marijuana using children lose IQ points. Not many reported on the follow-up study that could not replicate the first study. When eliminating co-founders, the new study found no drop in IQ points. Further, research on twin siblings showed that the drop in IQ was due to parenting, binge drinking or other societal influences, not marijuana. https://www.drugabuse.gov/news-events/nida-notes/2016/08/study-questions-role-marijuana-in-teen-users-iq-decline Try reading that last sentence again. In a world of science, evidence, reasoning and logic, a doctor makes a statement that decades of use of marijuana might make you lose intellectual function, based on conjecture. NIDA also continues to perpetuate the myth that Marijuana is a “gateway drug”. https://www.drugabuse.gov/publications/research-reports/marijuana/marijuana-gateway-drug These findings are consistent with the idea of marijuana as a "gateway drug." However, the majority of people who use marijuana do not go on to use other, "harder" substances. NIDA, NIH, FDA, DEA, including other federal, state, and local government organizations and private companies continue to perpetuate these and other lies in order to keep marijuana illegal. ASA has filed complaints against the DEA multiple times to get it to remove incorrect statements about marijuana off of the DEA’s website. http://www.safeaccessnow.org/iqa_victory A cyclical pattern emerges from the current and past situation surrounding marijuana. 1. Stymied scientific research, due to illegality of marijuana and government funding biases 2. Using stymied scientific research as a reason to ignore reality. 3. Repeating the biased scientific research, long after it was shown to be deficient. 4. Using the deficient biased research in “meta-reviews”. Thus taking bad science as a base to create more bad science just by doing an analysis of the bad science conclusions. 5. Even after a research study has been fully proven to be deficient and conflicting with better research, continue to hold it up as if it is still valid in some way. 6. Publish opinions as if they were facts, without any data to back up any claims. Continue reading for more conflicting studies and more calls for research. Marijuana: Prenatal and Postnatal Exposure in the Human Marijuana use in pregnancy and lactation: a review of the evidence Marijuana and Pregnancy The Association of Marijuana Use with Outcome of Pregnancy Prenatal Tobacco, Marijuana, Stimulant, and Opiate Exposure: Outcomes and Practice Implications Many of these studies contradict themselves. Some report differences in birth weight, some show no differences. Read the studies yourself! http://legislature.mi.gov/doc.aspx?2017-HB-5222 House bill 5422 will force MMFLA provisioning centers to give patients and caregivers an unscientific pamphlet, as described by the legislature. HB 5222 looks like it will pass. All this fear and doubt of a non-toxic 5,000+ year old medication used by millions of humans in every country in the world.

In 2010, Michigan State Police returned the medical marijuana they seized from our client during a traffic stop. The cannabis was returned after we obtained a dismissal of all charges in a court order directing the arresting agency to return the medical marijuana to our client.

We've known for forty years that Cannabidiol (CBD) from the Cannabis Sativa aka Marijuana aka Hemp plant vastly reduces many different kinds of seizures and epilepsy in humans. It is a travesty that patients and parents of children with epilepsy are prohibited from using this non-toxic plant to prevent and stop seizures. Tens of thousands of epileptics have died because they were unable to access this life saving safe non-toxic medication. Abstract In phase 1 of the study, 3 mg/kg daily of cannabidiol (CBD) was given for 30 days to 8 health human volunteers. Another 8 volunteers received the same number of identical capsules containing glucose as placebo in a double-blind setting. Neurological and physical examinations, blood and urine analysis, ECG and EEG were performed at weekly intervals. In phase 2 of the study, 15 patients suffering from secondary generalized epilepsy with temporal focus were randomly divided into two groups. Each patient received, in a double-blind procedure, 200-300 mg daily of CBD or placebo. The drugs were administered for along as 4 1/2 months. Clinical and laboratory examinations, EEG and ECG were performed at 15- or 30-day intervals. Throughout the experiment the patients continued to take the antiepileptic drugs prescribed before the experiment, although these drugs no longer controlled the signs of the disease. All patients and volunteers tolerated CBD very well and no signs of toxicity or serious side effects were detected on examination. 4 of the 8 CBD subjects remained almost free of convulsive crises throughout the experiment and 3 other patients demonstrated partial improvement in their clinical condition. CBD was ineffective in 1 patient. The clinical condition of 7 placebo patients remained unchanged whereas the condition of 1 patient clearly improved. The potential use of CBD as an antiepileptic drug and its possible potentiating effect on other antiepileptic drugs are discussed. https://www.ncbi.nlm.nih.gov/pubmed/7413719 Abstract A high dose of Δ⁹-tetrahydrocannabinol, the main Cannabis sativa (cannabis) component, induces anxiety and psychotic-like symptoms in healthy volunteers. These effects of Δ⁹-tetrahydrocannabinol are significantly reduced by cannabidiol (CBD), a cannabis constituent which is devoid of the typical effects of the plant. This observation led us to suspect that CBD could have anxiolytic and/or antipsychotic actions. Studies in animal models and in healthy volunteers clearly suggest an anxiolytic-like effect of CBD. The antipsychotic-like properties of CBD have been investigated in animal models using behavioral and neurochemical techniques which suggested that CBD has a pharmacological profile similar to that of atypical antipsychotic drugs. The results of two studies on healthy volunteers using perception of binocular depth inversion and ketamine-induced psychotic symptoms supported the proposal of the antipsychotic-like properties of CBD. In addition, open case reports of schizophrenic patients treated with CBD and a preliminary report of a controlled clinical trial comparing CBD with an atypical antipsychotic drug have confirmed that this cannabinoid can be a safe and well-tolerated alternative treatment for schizophrenia. Future studies of CBD in other psychotic conditions such as bipolar disorder and comparative studies of its antipsychotic effects with those produced by clozapine in schizophrenic patients are clearly indicated. (PsycINFO Database Record (c) 2016 APA, all rights reserved) http://psycnet.apa.org/record/2006-05687-001 Abstract BACKGROUND The Dravet syndrome is a complex childhood epilepsy disorder that is associated with drug-resistant seizures and a high mortality rate. We studied cannabidiol for the treatment of drug-resistant seizures in the Dravet syndrome. METHODS In this double-blind, placebo-controlled trial, we randomly assigned 120 children and young adults with the Dravet syndrome and drug-resistant seizures to receive either cannabidiol oral solution at a dose of 20 mg per kilogram of body weight per day or placebo, in addition to standard antiepileptic treatment. The primary end point was the change in convulsive-seizure frequency over a 14-week treatment period, as compared with a 4-week baseline period. RESULTS The median frequency of convulsive seizures per month decreased from 12.4 to 5.9 with cannabidiol, as compared with a decrease from 14.9 to 14.1 with placebo (adjusted median difference between the cannabidiol group and the placebo group in change in seizure frequency, −22.8 percentage points; 95% confidence interval [CI], −41.1 to −5.4; P=0.01). The percentage of patients who had at least a 50% reduction in convulsive-seizure frequency was 43% with cannabidiol and 27% with placebo (odds ratio, 2.00; 95% CI, 0.93 to 4.30; P=0.08). The patient’s overall condition improved by at least one category on the seven-category Caregiver Global Impression of Change scale in 62% of the cannabidiol group as compared with 34% of the placebo group (P=0.02). The frequency of total seizures of all types was significantly reduced with cannabidiol (P=0.03), but there was no significant reduction in nonconvulsive seizures. The percentage of patients who became seizure-free was 5% with cannabidiol and 0% with placebo (P=0.08). Adverse events that occurred more frequently in the cannabidiol group than in the placebo group included diarrhea, vomiting, fatigue, pyrexia, somnolence, and abnormal results on liver-function tests. There were more withdrawals from the trial in the cannabidiol group. CONCLUSIONS Among patients with the Dravet syndrome, cannabidiol resulted in a greater reduction in convulsive-seizure frequency than placebo and was associated with higher rates of adverse events. (Funded by GW Pharmaceuticals; ClinicalTrials.gov number, NCT02091375.) http://www.nejm.org/doi/full/10.1056/NEJMoa1611618 Muskegon mom hopes medical pot will save daughter, 5 Nina DeSarro, WZZMPublished 9:08 a.m. ET March 1, 2018 Can medical marijuana save Michigan girl? Could something so taboo, something the federal government doesn't recognize as containing medicinal value, be the cure for a 5-year-old girl in Muskegon? (Photo: WZZM) LeAnne Parker is a supermom. Between caring for her two daughters, her dogs and keeping up with her career, she does it all. “For four years my life was normal. My kids were normal. I knew nothing was wrong,” Parker said. That is until January 7, 2017 when her five-year-old daughter, Lily became unresponsive. “Her eyes just slowly start going to the right, almost like poltergeist, to the point where she turned her whole body until she was facing the shower which was behind her,” Parker said. In a panic, Parker immediately called an ambulance. “I didn’t know what to do, I just sat there and cried, I thought I was losing her, I just had the door open and I was just screaming for somebody to please help,” Parker remembered. Lily was taken to the hospital where doctors couldn't figure out what had happened. “They just said, 'if it happens again call us' and sent me home with no answers so we came home with no answers,” Parker said. Two weeks later, it happened again. And then again. “She did testing and testing and everybody said ‘I don’t know, just the brain is…welcome to the brain,’” Parker said. Finally in February, Lily received a diagnosis of epilepsy. “With two seizures that are unprovoked, you get the diagnosis of epilepsy.” She was immediately put on prescription medication, but the seizures continued. Lily had reached the maximum dosage possibly. “Now she’s failed all pharmaceuticals,” Parker said. Not only were the medications ineffective, her physical and mental state began to deteriorate. Five-year-old Lily was high, every day, her mom said. “I sent her to school the other day, and they called me and they said that she was tired. She was passing out. She fell asleep during circle,” Parker said. She picked Lily up from school after her teachers told her she was walking into walls. The only other option for Lily was brain surgery, if she would even qualify. “I thought, there has to be something else,” Parker said. Brain surgery could mean a loss of Lily’s peripheral vision. “And there’s a chance that it wouldn't even work, so then my daughter is partially blind and still has seizures, how do you make that choice for your kid, I don’t know,” Parker said. She would never be able to drive, never be able to play sports, that’s a really, really hard decision to make as a parent.” Desperate for another solution, Leanne found out about CBD, Cannabidiol. “I started doing my research so instead of doing all of my research about epilepsy, now I was doing all of my research about CBD oil and learning everything I possibly could to learn about the benefits of it,” Parker said. She went to a meeting in Grand Haven about medical marijuana’s use in treating epilepsy and from that point forward, she was going to give CBD a try. “It’s my daughter, so you can judge me. I feel like we live in a culture where it’s okay to pop Oxycontin, Vicodin and pain killers but we look at CBD oil like it’s awful, I don’t understand that,” Parker said. Nervous, Leanne approached her daughter’s neurologist with the idea. “I brought it up to my doctor hoping and praying that he was on board with it and a lot of people aren’t I’m lucky that I found a doctor that is, because if he wasn’t, I’d have to do it behind his back,” Parker said. Weeks later, she received Lily’s medical marijuana license in the mail. “The sad part is, there’s no doctor to talk to and that is the most frustrating part with me, because I’m like ‘okay I’m on board I want to do this, how, where, what do I do, how do I go about it and how do I even know how to dose my daughter?’” Parker said. Through her research, she found Bloom. The Ann Arbor based medical marijuana facility that offers doctor/patient consulting. “I wish this was option one before the pharmaceuticals, I wish I would have tried this first,” Parker said. It’s still a little too early today, but it’s been 25 days seizure free for Lily. “I am not hopping on a bandwagon of medical marijuana, I’m jumping off of the pharmaceutical bandwagon,” Parker said. So far, this is the longest Lily has gone without having a seizure since July of 2017. https://www.freep.com/story/news/local/michigan/2018/03/01/muskegon-medical-marijuana-leanna-parker/384280002/

As this news hit in the last throes of 2017, it seems appropriate to take a step back and understand why exactly marijuana was banned all of those years ago. Please continue reading to find the answers on this long and weird journey through time. Elderly Couple Stopped In Nebraska With 60 Pounds Of Weed ‘For Christmas Presents’ With the help of the county’s canine unit, deputies searched the Toyota Tacoma. When they looked under the pickup topper, deputies found 60 pounds of marijuana, as well as multiple containers of concentrated THC. “They said the marijuana was for Christmas presents,” Lt. Paul Vrbka told the York News-Times. The department estimated the street value of the pot at over $300,000. The Jirons now face felony charges of possession of marijuana with the intent to deliver and no drug tax stamp. (Nebraska law requires marijuana dealers to purchase drug tax stamp from its Department of Revenue as evidence that the state’s drug tax has been paid.) For the friends and family in New England who expected a bag of weed in their stocking this year, it looks like it won’t be a green Christmas, after all. https://www.npr.org/sections/thetwo-way/2017/12/22/572844666/elderly-couple-stopped-in-nebraska-with-60-pounds-of-weed-for-christmas-presents Marijuana (also known as cannabis sativa or cannabis indica or hemp) has been a medicine for thousands of years. Marijuana is found in all recorded history, on every continent as a medicinal crop. Egypt to China to India to Assyria (Iraq) and Arabia. From the Greeks and Romans to present day. In the early USA, hemp was an integral part of life. George Washington grew hemp and many colonists grew hemp for cordage and canvas, including ropes and sails for ships. Newspapers in 1841 went into great detail on how to cultivate hemp, including separating the male plants from the female plants. Many papers also reported stories about having a laugh while smoking hemp, as is the case with this 1850 report from a Paris correspondent for the Medical Times. (click for a larger view) There are many examples in American newspapers including poems, insults, references and propaganda on the subject of hasheesh (the old timey spelling of hashish), marijuana, cannabis and hemp. Just look at this article from 1908, they found marihuana in this man’s pocket! 1906 – The Pure Food and Drugs Act Requires Labeling of ingredients of Medicine, Including Cannabis. Previous to the Pure Food and Drugs Act, many medicines were treated the way Coca-Cola is today. “A secret formula” or “A proprietary blend” of spices and medicines and even poisons including arsenic and strychnine. Writing cannabis on a label did not ban cannabis related medications. Many major pharmaceutical companies which are still around today, used to sell cannabis based medicines. Pharmacists used to make cannabis based compounds and elixirs and extracts and pills as well. Newspapers had been printing a lot of yellow journalism on the subject of marijuana over a number of years. Articles were passed around from newspaper to newspaper, with editors changing and inserting local opinion into the reprinted stories. Sample Articles from Chronicling America: These are only a handful of articles, more comprehensive research must be done. “Senseless Brutality. A Mexican Priest Flogs the Corpse of a Dead Wizard.,” The Memphis Appeal(Memphis, TN) , April 18, 1887, Page 1, Image 1, col. 6. “Victims of a Mexican Drug. From the Mexican Herald.,” The Sun (New York, NY), August 12, 1897, Page 6, Image 6, col. 5. The New York Sun relays a report from the Mexican Herald that “Marihuana, our local hasheesh, continues to impel people of the lower orders to wild and desperate deeds.” “Stronger Than Opium. Attempt to Smuggle Mariguana into Yuma Prison.,” Tombstone Prospector(Tombstone, AZ), September 15, 1897, Page 4, Image 4, col. 4. “Across the border. Mexican Herald.,” The Oasis (Arizola, AZ), July 15, 1899, Page 6, Image 6, col. 1. A report from the Mexican Herald of a scene in a civil registry office: “A marihuana fiend suddenly appeared in the office brandishing a knife, declared that he was Herod and his mission was the extermination of new-born infants.” “Across the border. Two Republics.,” The Oasis (Arizola, AZ), December 30, 1899, Page 10, Image 10, col. 1. “Dangerous Mexican Weed to Smoke,” Phipllipsburg Herald (Phillipsburg, KS), August 18, 1904, Page 8, Image 8, col. 3. “Teacher Starr of Chicago Man of Sensations,” San Francisco Call (San Francisco, CA), August 25, 1905, Page 8, Image 8, col. 2. “Stops Sale of Maddening Drug,” New-York Tribune (New York, NY), December 24, 1905, Page 3, Image 3, col. 4. “War on Marihuana Smoking. Mexican Government Wants to Exterminate a Weed That Crazes,” The Sun(NewYork, NY), May 26, 1907, Page 17, Image 17, col. 4. “Use for Deadly Weed. Mexican Marihuana Plant to be Grown in Texas for Drug Purposes.,” Florida Star(Titusville, FL), October 16, 1908, Page 3, Image 3, col. 4. The Florida Star reports that James Love, who operates an agricultural experimental station in Texas, has received permission from the state agricultural department to plant in Texas ten pounds of marihuana seed he has imported from Mexico. The article states Mr. Love’s belief is that the plant “can be put to good commercial use as a drug.” “Goats that Feed on Dope,” New-York Tribune (New York, NY), April 11, 1909, Page 55, Image 55, col. 5. A fanciful tale of an alleged Mexican goat-herder whose goats have become addicted to marihuana. “Yerbas Medicinales [Marihuana advertised for sale],” La Revista de Taos (Taos, NM), February 7, 1913, Page 4, Image 4, col. 7. “On Account of His Oriental Nature the Mexican’s Mind is a Puzzle to the Foreigner,” The Sun (New York, NY), May 17, 1914, Page 37, Image 37, col. 1. “Marihuana Sale Now Prohibited. Council Passes Emergency Ordinance to Stop Sale of Mexican Drug.,” El Paso Herald (El Paso, TX), June 3, 1915, Page 6, Image 6, col. 3. “New Anti-marijuana Ordinance Very Stringent,” El Paso Herald (El Paso, TX), June 7, 1915, Page 9, Image 9, col. 3. The El Paso Herald reports concern from local physicians and pharmacists over El Paso’s prospective anti-marihuana law. The Herald’s article states that “It is put up by the foremost drug manufacturers in the country and is frequently prescribed, as it is a sedative of value.” “Is the Mexican Nation ‘Locoed’ by a Peculiar Weed?,” The Ogden Standard (Ogden City, UT), September 25, 1915, Page 13, Image 13, col. 1. Mexican “bandits” are being emboldened to take on Uncle Sam by the intoxicating effects of marihuana. “Marihuana Smokers Shut Off from their ‘Makins’,” El Paso Herald (El Paso, TX), September 13, 1917, Page 6, Image 6, col. 3. “The One Wicked Drug the Lawmakers Forgot,” The Ogden Standard-Examiner (Ogden, UT), December 24, 1922, Page 24, Image 24, col. 1. The Mexican Revolution in 1910 caused many Mexicans to move to the USA. Racism and xenophobia increased in the bordering states. Residents and leaders wanted any and all excuses to jail and deport Mexicans. According to various timelines of the history of marijuana, the first anti-marijuana laws started in individual southern states bordering Mexico. Racism was used against marijuana during international treaties and drug control laws as well. Historians cannot find the reason why Canada banned cannabis in the 1920s, except for racism against the Chinese. Cannabis prohibition was based on and helped by alcohol prohibition. Alcohol prohibition, largely thought of as targeting alcohol itself, was chiefly about prohibiting saloons. The Saloons of the 1800s and 1900s also hosted gambling, dancing with women, vaudeville, musical shows and frequently employed saloon girls to entice and encourage alcohol consumption. “The Saloon Must Go” was the Anti Saloon League’s motto. “That prohibition of the sale of liquor would reduce the prevalence of commercialized prostitution is evident from the efforts which have been made to separate the sale of liquor from the prostitution in certain cities which tolerated vice or segregated districts.” says George J Kneeland (Social Hygiene ,Jan 1916.) Music, dancing, girls and musicians? Sounds very similar to the REEFER MADNESS propaganda against Jazz Clubs in the 1930s. From the Senate Hearing on Juvenile Delinquency and Marijuana Decriminalization, including 4 years of research during 1971-1975, no clues were found to explain why marijuana was banned. Why was marijuana banned? Racism against blacks, Mexicans and “undesirables” Harry J Anslinger was a racist and a liar. Marijuana continues to be banned because: Selective police action enforces racism Competition from pharmaceutical companies Nixon hated protesting hippies. Competition from the Alcohol industry Police and Prison guard unions want marijuana prisoners Uninformed do-gooders like MADD, who have not seen the statistics of lower alcohol driving deaths in states that have legalized marijuana. Evangelical Christians, Catholics and other religious groups. Jeff Sessions and Chris Christie.

The Michigan State Police are hiring! They are looking for a “Narcotics Intelligence Analyst” to “Focus on providing assistance to the Medical Marihuana Investigation Section (MMIS) with marihuana investigations related to the Michigan Medical Marihuana Act, Medical Marihuana Facilities Licensing Act, and Marihuana Tracking Act.” There is also a position available for a combination Marihuana and Tobacco Tax Investigation Section within the State Police. One of the duties of this MSP Trooper Tax Enforcer position is to coordinate with Federal enforcement agencies and prosecutors. Maintain a working relationship with courts, prosecutors and other enforcement agencies at federal, state and local levels. Initiate positive interaction with court personnel, federal, county and state prosecutors. Assist federal, state and local law enforcement agencies on complaints related to theft of cigarettes and all tobacco smuggling. It is interesting that the Michigan State Police are now getting on board with Medical Marihuana in Michigan. Official statements and policy by the MSP in the past have all been against the MMMA and MMFLA at multiple points. https://www.southbendtribune.com/news/local/new-laws-in-michigan-shake-up-the-marijuana-industry/article_21fd1838-50a3-5281-a65a-06ebba9ca838.html http://www.detroitnews.com/story/news/local/michigan/2018/01/01/medical-marijuana-enforcement-grants-michigan/109087886/ When the MMMA became law, police officers were not trained how to handle medical marijuana situations. Ken Stecker from the Prosecuting Attorneys Association of Michigan did a reefer madness type propaganda power point presentation around the state explaining the MMMA to various law enforcement agents and organizations. Ken Stecker included propaganda such as this in his “updated presentation” on Michigan’s Medical Marihuana Program. Why was a person, not affiliated in any way with the State of Michigan, going around doing talks with local, county and state police officers about a medical law? What is this Medical Marijuana Investigation Section? The House Legislative Analysis explains what HB 4209 (Public Act 281 of 2016) aka the MMFLA does for law enforcement: The Department of State Police (MSP) would provide 34.0 FTEs for criminal enforcement activities related to medical marihuana at an annual cost of $6.0 million. This assumption is based on the personnel employed by the MSP to provide criminal enforcement activities for the Michigan Casino Gaming Board (MGCB). The Department of Attorney General (AG) would provide 4.0 FTEs for legal and prosecutorial support related to medical marihuana at an annual cost of $500,000. After being against the MMMA, the MMFLA, patients, caregivers, and everything possibly to do with medical marijuana, the Michigan State Police now have to regulate and enforce it. Compliance Checks? Marijuana Tracking ACT ? The Seed to Sale , or Marijuana Tracking ACT is a law in Michigan to track and report all sales, transfers, processes, manufacturing and cultivation within the MMFLA. It allows law enforcement agencies to verify and enforce regulations in the MMFLA, including the tracking of patient and caregiver purchases within the retail state-licensed MMFLA dispensaries. Ultimately, the police have inserted themselves between you and your doctor. The police asked for these regulations during the MMFLA law drafting committees and senate and house hearings on these bills. The police want to look at the MMFLA registry and if you have bought too much marijuana from the system within some random arbitrary window of time, they are going to want to investigate you. Just for the medical use of marijuana as granted by the State of Michigan. It is sad that the police are enforcing patient’s medication with jail time.

MMJ Eases Some MS Symptoms, Neurologists Report USA -- There is strong evidence that medical marijuana pills may reduce symptoms of spasticity and pain reported by multiple sclerosis patients, but little proof that smoking pot offers the same benefit, according to new alternative treatment guidelines released by the American Academy of Neurology. The guidelines on complementary and alternative medicine, or CAM, treatments for MS were published Monday in the journal Neurology and are among the first from a national medical organization to suggest that doctors might offer cannabis treatment to patients. Read More...

USA -- Using marijuana does not cause changes in brain volume, a new study suggests.Public health experts have cited concerns that using marijuana could be associated with structural changes in the brain. However, a new trial comparing the brains of marijuana users and non-users to their siblings reveals that marijuana use likely does not cause changes in brain volume. Read More...

Israel -- Scientists in Israel are exploring another medical use for marijuana: Their research indicates that a compound in the plant helps heal bone fractures. The new study, published in the Journal of Bone and Mineral Research, found that broken bones healed faster and stronger when the patient received the non-psychoactive compound cannabidiol, or CBD. Read More...

Denver -- Colorado has made an unusual plea to federal authorities: Let our colleges grow pot. In a letter sent last month, the state attorney general's office asks federal health and education officials for permission for Colorado's colleges and universities to "obtain marijuana from non-federal government sources" for research purposes. Read More...

Congress Puts Stop to War on Medical Marijuana with Protections Amendment Dec 15, 2014 On Saturday, Senate approved a $1.1 trillion spending package to keep the government running. Tucked away in that package was an amendment that will block the Department of Justice from arresting or prosecuting anyone who sells or uses medical marijuana in the 34 states that have some form of medical marijuana law on record. This will stop the DOJ from conducting raids on medical marijuana dispensaries and stop them from arresting individuals involved in the medical marijuana industry who are complying with state law. The new amendment also has protections for industrial hemp. President Obama is expected to approve the bill. Once he does, the new amendment has the potential to impact a number of pending cases against medical marijuana business owners and patients who have been targeted by the federal government despite complying with local and state laws. “When the House first passed this measure back in May, we made headlines; today we made history,” Rep. Sam Farr (D-Calif.), who in May introduced the medical marijuana protections amendment with co-sponsor Rep. Dana Rohrabacher (R-Calif.), told The Huffington Post regarding the bill’s passage. “The federal government will finally respect the decisions made by the majority of states that passed medical marijuana laws,” Farr added. “This is great day for common sense because now our federal dollars will be spent more wisely on prosecuting criminals and not sick patients.” A statement issued by Americans for Safe Access following the spending bill’s passage Saturday called the measure “historic” and said patients’ rights advocates believe it “will dramatically impact DOJ enforcement, including ending federal medical marijuana raids, arrests, criminal prosecutions, and civil asset forfeiture lawsuits.”

USA -- If you're confused about what marijuana use really does to people who use it, you're not alone. For years, the scientific research on health effects of the drug have been all over the map. Earlier this year, one study suggested that even casual marijuana use could cause changes to the brain. Another found that marijuana use was also associated with poor sperm quality, which could lead to infertility in men. Read More...

In a breakthrough decision for those who say marijuana is medicine and not a dangerous drug, the Michigan Court of Appeals ruled Friday that workers who are state-approved users of medical marijuana should get unemployment compensation if fired solely for testing positive for drugs. "It's a very favorable decision for the civil rights of employees in Michigan," said Matt Abel, a Detroit lawyer and senior partner of Cannabis Counsel, a law firm that focuses on marijuana cases. But Rich Studley, president of the Michigan Chamber of Commerce, said the ruling -- and the use of medical marijuana in general -- present "a real dilemma" for employers. "There's a serious question of workplace safety when people may use medical marijuana before they come to work" and then operate machinery or do other tasks that could endanger others, Studley said. He said he hoped the ruling would be appealed. The Chamber of Commerce filed an amicus brief in the case in opposition to allowing jobless benefits to medical-pot users. Michigan has had numerous cases of workers who, after receiving years of good performance evaluations, were terminated when they failed on-the-job drug tests because of their medical marijuana use, Abel said. "This decision is another acknowledgment that medical-marijuana users' rights have been unfairly infringed. "They still can be fired for medical-marijuana use — even off the job, which we think is wrong. But now, at least they can't be barred from unemployment benefits for that reason alone," said Abel, who also is the executive director of Michigan NORML, the state's chapter of a nationwide group that favors legalizing the drug. Friday's decision applies only to Michiganders who are state-registered users of the drug. The decision affirmed lower court decisions that the state's medical marijuana law preempted its unemployment law. A three-judge Appeals Court panel found that three state courts rightly reversed a decision by the Michigan Compensation Appellate Commission to deny three workers their compensation after they were fired by their employers for testing positive for marijuana. The decision said that a provision of Michigan's medical marijuana act, passed by voters in 2008, prohibits penalties for those who use medical marijuana legally. The decision encompassed separate cases from across the state in which three employees had been fired from their jobs after allegedly violating their employers' worksite policies by testing positive for marijuana. Each possessed a state-issued medical marijuana card, demonstrating that a medical doctor had approved their use of the drug to treat a health condition. Administrative law judges in each case had ruled in favor of forklift operator Rick Braska, CT technician Jenine Kemp and furniture-repair technician Stephen Kudzia. "This is not the ultimate victory but it's a big step in the right direction," said medical-marijuana user Steven Greene, 47, of Lyon Township. "Right now, marijuana is still classified with the federal government as a Schedule I dangerous drug, the same as heroin, which is so destructive to people's health. That's keeping a lot of society from accepting it and keeping a lot of employers from accepting it," said Greene, a candidate for trustee in Lyon Township. http://www.freep.com/story/news/local/michigan/2014/10/24/medical-marijuana-michigan-unemployment-compensation/17866619/ Contact Bill Laitner: blaitner@freepress.com

USA -- America has a major problem with prescription pain medications like Vicodin and OxyContin. Overdose deaths from these pharmaceutical opioids have approximately tripled since 1991, and every day 46 people die of such overdoses in the United States. However, in the 13 states that passed laws allowing for the use of medical marijuana between 1999 and 2010, 25 percent fewer people die from opioid overdoses annually. Read More...

Washington, D.C. -- Reflecting growing national acceptance of cannabis, a bipartisan coalition of House members voted early Friday to restrict the Drug Enforcement Administration from using funds to go after medical marijuana operations that are legal under state laws. An appropriations amendment offered by Rep. Dana Rohrabacher (R-Calif.) prohibiting the DEA from spending funds to arrest state-licensed medical marijuana patients and providers passed 219-189. The Senate will likely consider its own appropriations bill for the DEA, and the House amendment would have to survive a joint conference before it could go into effect. Read More...

Florida -- The stakes are getting higher - politically and financially - in Florida's heated campaign over a November referendum to allow doctors to prescribe marijuana. The latest financial reports by the two main groups fighting the legalization of medical marijuana show a total of more than $7.7 million has been raised to oppose the constitutional amendment on the Nov. 4 ballot. Read More...